Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Differential Effects of Anthracycline-based Neoadjuvant Chemotherapy on Stromal and Intratumoral FOXP3+ Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer of No Special Type

The Indonesian Biomedical Journal · Vol. 16 No. 2 (2024) · hlm. 135–143

DOI
10.18585/inabj.v16i2.2828
ISSN
2085-3297, 2355-9179
Terbit
2024-04-30
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Neoadjuvant chemotherapy (NAC) plays a crucial role in the management of invasive breast cancer with no special type (IBC-NST), with the immune system's response to cancer heavily relying on the dynamics between tumor-infiltrating lymphocytes (TILs) and cancer cells. In this study, the differential effects of anthracycline-based NAC on stromal and intratumoral foxhead box P3 (FOXP3+) TILs expressions were specifically examined.METHODS: In this cross-sectional study, 32 IBC-NST samples were evaluated for pre- and post-NAC FOXP3+ TIL expression as well as the changes of FOXP3+ TIL expression. Comprehensive data collection regarding subjects' age, tumor size, grade, lymphovascular invasion, regional lymph node metastasis, and receptor status were conducted. Immunohistochemistry was utilized to quantify FOXP3+ TILs. The stromal, intratumoral and total FOXP3+ TILs expression were then analyzed.RESULTS: Significant reductions in FOXP3+ TIL expression post-NAC were observed, with stromal FOXP3+ TILs showing a median decrease of 3.6 units in subjetcs aged ≥50 years (p=0.013) and a median decrease of 13.2 units in subjects with tumors ≥5 cm after NAC (p=0.006). In contrast, intratumoral FOXP3+ TILs remained relatively stable, with minor changes. The total FOXP3+ TIL expression, combining stromal and intratumoral components, was significantly decreased with a median of 13.0 units decreased to 5.3 units (p<0.001).CONCLUSION: This study highlights the significant reduction in stromal FOXP3+ TIL expression after NAC treatment in IBC-NST subjects, in contrast to the relatively stable intratumoral FOXP3+ TILs. Understanding these differences may guide future therapeutic strategies and improve treatment outcomes for IBC-NST.KEYWORDS: biomarkers, chemotherapy, FOXP3, prognostic, response, lymphocyte

Kata kunci

Jaringan kolaborasi para penulis

25 penulis · 100 tautan kepenulisan bersama · 75 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Yarsi University
  • Dharmais Cancer Hospital
  • Riau University
  • Universitas Trisakti
  • Padjadjaran University
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Ferry SandraUniversitas Trisakti3
Sonar Soni PanigoroRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Herqutanto HerqutantoUniversity of Indonesia2
Ahmad KurniaUniversity of Indonesia2
Denni Joko PurwantoDharmais Cancer Hospital2
Harliansyah HarliansyahYarsi University1
Nunung Ainur RahmahYarsi University1
Fransiscus D. SuyatnaUniversity of Indonesia1
Mpu KanokoUniversity of Indonesia1
Joedo PrihartonoUniversity of Indonesia1
Samuel Johny HaryonoDharmais Cancer Hospital1
Bethy Suryawati HernowoPadjadjaran University1
Al RasyidRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Heri WibowoUniversity of Indonesia1
Aria KekalihUniversity of Indonesia1
Suhendro SuwartoRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Alida Roswita HarahapUniversity of Indonesia1
Nuri Dyah IndrasariRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1
Ida ParwatiDr. Hasan Sadikin General Hospital1
Marcellus SimadibrataUniversity of Indonesia1
Yusra YusraRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Differential Effects of Anthracycline-based Neoadjuvant Chemotherapy on Stromal and Intratumoral FOXP3+ Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer of No Special Type</dc:title><dc:creator>Primariadewi Rustamadji</dc:creator><dc:creator>Elvan Wiyarta</dc:creator><dc:creator>Meike Pramono</dc:creator><dc:creator>Sinta Chaira Maulanisa</dc:creator><dc:subject>Foxp3+ T cells</dc:subject><dc:subject>tumor-infiltrating lymphocytes</dc:subject><dc:subject>stromal TILs</dc:subject><dc:subject>tumor immune microenvironment</dc:subject><dc:subject>tumor size</dc:subject><dc:subject>age</dc:subject><dc:subject>prognostic factors</dc:subject><dc:subject>treatment response</dc:subject><dc:description xml:lang="en">BACKGROUND: Neoadjuvant chemotherapy (NAC) plays a crucial role in the management of invasive breast cancer with no special type (IBC-NST), with the immune system's response to cancer heavily relying on the dynamics between tumor-infiltrating lymphocytes (TILs) and cancer cells. In this study, the differential effects of anthracycline-based NAC on stromal and intratumoral foxhead box P3 (FOXP3+) TILs expressions were specifically examined.METHODS: In this cross-sectional study, 32 IBC-NST samples were evaluated for pre- and post-NAC FOXP3+ TIL expression as well as the changes of FOXP3+ TIL expression. Comprehensive data collection regarding subjects' age, tumor size, grade, lymphovascular invasion, regional lymph node metastasis, and receptor status were conducted. Immunohistochemistry was utilized to quantify FOXP3+ TILs. The stromal, intratumoral and total FOXP3+ TILs expression were then analyzed.RESULTS: Significant reductions in FOXP3+ TIL expression post-NAC were observed, with stromal FOXP3+ TILs showing a median decrease of 3.6 units in subjetcs aged ≥50 years (p=0.013) and a median decrease of 13.2 units in subjects with tumors ≥5 cm after NAC (p=0.006). In contrast, intratumoral FOXP3+ TILs remained relatively stable, with minor changes. The total FOXP3+ TIL expression, combining stromal and intratumoral components, was significantly decreased with a median of 13.0 units decreased to 5.3 units (p&lt;0.001).CONCLUSION: This study highlights the significant reduction in stromal FOXP3+ TIL expression after NAC treatment in IBC-NST subjects, in contrast to the relatively stable intratumoral FOXP3+ TILs. Understanding these differences may guide future therapeutic strategies and improve treatment outcomes for IBC-NST.KEYWORDS: biomarkers, chemotherapy, FOXP3, prognostic, response, lymphocyte</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2024-04-30</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>http://dx.doi.org/10.18585/inabj.v16i2.2828</dc:identifier><dc:identifier>10.18585/inabj.v16i2.2828</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 16 No 2 (2024); 135-143</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2828/697</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>